Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells

European Journal of Immunology

Volumn 38, Issue 3, 2008, Pages 742-749

  Gros, Frédéric ^a   Cabillic, Florian ^a,b   Tourirais, Olivier ^a   Le Maux, Amélie ^a   Sebti, Yasmine ^a   Amiot, Laurence ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

DC; HLA G; Immunomodulation; NK cells; NK DC crosstalk

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA-G ANTIGEN; IMMUNOGLOBULIN RECEPTOR; IMMUNOLOGIC FACTOR; LEUKOCYTE ANTIGEN; LILRB1 PROTEIN, HUMAN; LILRB2 PROTEIN, HUMAN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; T LYMPHOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MEDIATED CYTOTOXICITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DAUDI CELL; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; NATURAL KILLER CELL; PRIORITY JOURNAL; CELL COMMUNICATION; CYTOTOXICITY; CYTOTOXICITY TEST; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL COMMUNICATION; COCULTURE TECHNIQUES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC;

EID: 43649104999     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200736918     Document Type: Article

References (43)

1. Kovats, S., Main, E. K., Librach, C., Stubblebine., M., Fisher, S. J. and DeMars, R., A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990. 248: 220-223.
2. Rouas-Freiss, N., Goncalves, R. M., Menier, C., Dausset J. and Carosella, E. D., Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA 1997. 94 11520-11525.
3. Blaschitz, A., Lenfant, F., Mallet, V., Hartmann, M., Bensussan, A., Geraghty, D. E., Le Bouteiller, P. et al., Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur. J. Immunol. 1997. 27: 3380-3388.
4. Crisa, L., McMaster, M. T., Ishii, J. K., Fisher, S. J. and Salomon, D. R., Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J. Exp. Med. 1997. 186: 289-298.
5. Ishitani, A. and Geraghty, D. E., Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc, Natl. Acad. Sci. USA 1992. 89: 3947-3951.
6. Kirszenbaum, M., Moreau, P., Gluckman, E., Dausset, J. and Carosella, E., An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc. Natl. Acad. Sd. USA 1994. 91: 4209-4213.
7. Fujii, T., Ishitani, A. and Geraghty, D. E., A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 1994. 153: 5516-5524.
8. Paul, P., Cabestre, F. A., Ibrahim, E. C., Lefebvre, S., Khalil-Daher, I., Vazeux, G., Quiles, R. M. et al., Identification of HLA-G7 as a new splice variant of the HLA-G mRNA aud expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum. Immunol. 2000. 61: 1138-1149.
9. Park, G. M., Lee, S., Park B., Kim, E., Shin, J., Cho, K. and Ahn, K., Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem. Biophys. Res. Commun. 2004. 313: 606-611.
10. Dong, Y., Lieskovska, J., Kedrin, D., Porcelli, S., Mandelboim, O. and Bushkin, Y., Soluble nonclassical HLA generated by the metalloproteinase pathway. Hum. Immunol. 2003. 64: 802-810.
11. + T cell regulatory mechanism. Proc. Natl. Acad. Sci. USA 2001. 98: 12150-12155.
12. Le Friec, G., Laupeze, B., Fardel, O., Sebti, Y., Pangault, C., Guilloux, V., Beauplet, A. et al., Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum. Immunol. 2003. 64: 752-761.
13. Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss, E. H. et al., A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape. J. Immunol. 2002. 168: 4772-4780.
14. Wiendl, H., Mitsdoerffer, M. and Weller, M., Hide-and-seek in the brain: A role for HLA-G mediating immune privilege for glioma cells. Semin. Cancer Biol. 2003. 13: 343-351.
15. Wiendl, H., Behrens, L., Maier, S., Johnson, M. A., Weiss, E. H. and Hohlfeld, R., Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Ann. Neurol. 2000. 48: 679-684.
16. Le Bond, S., Azema, C., Krawice-Radanne, I., Durrbach, A., Guettier, C., Carosella, E. D. and Rouas-Freiss, N., Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J. Immunol. 2006. 176: 3266-3276.
17. Chumbley, G., King, A., Robertson, K., Holmes, N. and Loke, Y. W., Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell. Immunol. 1994. 155: 312-322.
18. Rouas-Freiss, N., Marchal, R. E., Kirszenbaum, M., Dausset, J. and Carosella, E. D., The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc. Natl. Acad. Sci. USA 1997. 94: 5249-5254.
19. + cells by interacting with CD8. J. Immunol. 2000. 164: 6100-6104.
20. Lindaman, A., Dowden, A. and Zavazava, N., Soluble HLA-G molecules induce apoptosis in natural killer cells. Am. J. Reprod. Immunol. 2006. 56: 68-76.
21. Fons, P., Chabot, S., Cartwright, J. E., Lenfant, F., L'Faqihi, F., Giustiniani, J., Herault, J. P. et al., Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 2006. 108: 2608-2615.
22. Navarro, F., Llano, M., Bellon, T., Colonna, M., Geraghty, D. E. and Lopez-Botet, M., The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 1999. 29: 277-283.
23. Shiroishi, M., Kuroki, K., Ose, T., Rasubala, L., Shiratori, I., Arase, H., Tsumoto, K. et al., Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J. Biol. Chem. 2006. 281: 10439-10447.
24. Le Friec, G., Gros, F., Sebti, Y., Guilloux, V., Pangault, C., Fauchet, R. and Amiot, L., Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules. J. Leukoc. Biol. 2004. 76: 1125-1133.
25. Yie, S.M., Li, L. H., Li, Y. M. and Librach, C., HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am. J. Obstet. Gynecol. 2004. 191: 525-529.
26. Gros, F., Sebti, Y., de Guibert, S., Branger, B., Bernard, M., Fauchet, R. and Amiot, L., Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia 2006. 8: 223-230.
27. Sebti, Y., Le Maux, A., Gros, F., De Guibert, S., Pangault, C., Rouas-Freiss, N., Bernard, M. et al., Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. Br. J. Haematol. 2007. 138: 202-212.
28. Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. et al., Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 2003. 100: 8856-8861.
29. + T cells. Proc. Natl. Acad. Sci. USA 2004. 101: 7064-7069.
30. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X. Y., Rennert, P. D., Gray, G. S. et al., B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995. 2: 523-532.
31. Manzotti, C. N., Liu, M. K., Burke, F., Dussably, L., Zheng, Y. and Sansom, D. M., Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86. Eur. J. Immunol. 2006. 36: 1413-1422.
32. Ristich, V., Liang, S., Zhang, W., Wu, J. and Horuzsko, A., Tolerization of dendritic cells by HLA-G. Eur. J. Immunol. 2005. 35: 1133-1142.
33. LeMaoult, J., Zafaranloo, K., Le Danff, C. and Carosella, E. D., HLA-G upregulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 2005. 19: 662-664.
34. Guillard, C., Zidi, I., Marcou, C., Menier, C., Carosella, E. D. and Moreau, P., Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cells. Mol. Immunol. 2008. 45: 419-427
35. Chuang, S. S., Kumaresan, P. R. and Mathew, P. A., 2B4 (CD244)-mediated activation of cytotocicity and IFN-gamma release in human NK cells involves distinct pathways. J. Immunol. 2001. 167: 6210-6216.
36. Girart, M. V., Fuertes, M. B., Domaica, C. I., Rossi, L. E. and Zwirner, N. W., Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotocicity by human NK cells stimulated with suboptimal doses of IL-12. J. Immunol. 2007. 179: 3472-3479.
37. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. and Munz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002. 195: 343-351.
38. Vitale, M., Della Chiesa, M., Carlomagno, S., Pende, D., Arico, M., Moretta, L. and Moretta, A., NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005. 106: 566-571.
39. Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B. et al., NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004. 104: 3267-3275.
40. - natural killer cells is selectively responsible for both cell proliferation and interferongamma production upon interaction with dendritic cells. Eur. J. Immunol. 2004. 34: 1715-1722.
41. Lucas, M., Schachterle, W., Oberle, K., Aichele, P. and Diefenbach, A., Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007. 26: 503-517.
42. Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G. and Trinchieri, G., Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 2002. 195: 327-333.
43. Adrian Cabestre, F., Moreau, P., Riteau, B., Ibrahim, E. C., Le Danff, C., Dausset, J., Rouas-Freiss, N. et al., HLA-G expression in human melanoma cells: Protection from NK cytolysis. J. Reprod. Immunol. 1999. 43: 183-193.